Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 387

The DOI matches its Crossref record.

Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy

Open access
Thavendiranathan, Paaladinesh, Negishi, Tomoko, Somerset, Emily, Negishi, Kazuaki, Penicka, Martin, Lemieux, Julie, Aakhus, Svend, Miyazaki, Sakiko, Shirazi, Mitra, Galderisi, Maurizio, Marwick, Thomas H., Negishi, Kazuaki, Costello, Ben, Wright, Leah, La Gerche, Andre, Mottram, Phil, Thomas, Liza, Shirazi, Mitra, Penicka, Martin, Ondrus, Tomas, Seldrum, Stephanie, Hristova, Krassimira, Thavendiranathan, Paaladinesh, Amir, Eitan, Thampinathan, Babitha, Lemieux, Julie, Cote, Marc-Andre, Deblois, Jonathan, Bansal, Manish, Galderisi, Maurizio, Santoro, Ciro, Kurosawa, Koji, Fukuda, Nobuaki, Yamada, Hirotsugu, Saijo, Yoshihito, Miyazaki, Sakiko, Izumo, Masaki, Suzuki, Tomomi, Tajiri, Kazuko, Cho, Goo Yeong, Aakhus, Svend, Murbræch, Klaus, Massey, Richard, Kosmala, Wojciech, Sinski, Maciej, Vinereanu, Dragos, Mihalcea, Diana, Popescu, Bogdan, Calin, Andreea, Shkolnik, Evgeny, Banchs, Jose, Kutty, Shelby·2021·Journal of the American College of Cardiology

Abstract

BACKGROUND In patients at risk of cancer therapy-related cardiac dysfunction (CTRCD), initiation of cardio-protective therapy (CPT) is constrained by the low sensitivity of EF for minor changes in LV function. Global longitudinal strain (GLS) is a robust and sensitive marker of LV dysfunction, but existing observational data have been insufficient to support a routine GLS-guided strategy for CPT. OBJECTIVE To identify whether GLS-guided CPT prevents reduction in LVEF in patients undergoing potentially cardiotoxic chemotherapy, compared with usual care. METHODS In this international multicenter prospective randomized controlled trial, 331 anthracycline-treated patients with another heart failure risk factor were randomly allocated to CPT initiation guided by either ≥12% relative reduction in GLS (n=166) or >10% absolute reduction of LVEF (n=165). Patients were followed for EF and development of CTRCD (symptomatic EF reduction >5% or >10% asymptomatic to <55%) over 1 year. RESULTS Of 331 randomized patients, 2 died and 22 withdrew consent or were lost to follow-up. Among 307 patients (age 54±12 years, 94% women, baseline LVEF 59±6%, GLS -20.6±2.4%) with a median (IQR) follow-up of 1.02 (0.98-1.07) years, most (n=278) had breast cancer. HF risk factors were prevalent: 29% had hypertension and 13% had diabetes mellitus. At 1-year follow-up, although the primary outcome of change in LVEF was not significantly different between the two arms, there was significantly greater use of CPT, and fewer patients met CTRCD criteria in the GLS-guided than the EF-guided arm (5.8% vs 13.7%, p=0.02), and 1-year EF was 57±6% versus 55±7% (p=0.05). Patients diagnosed with CTRCD in the EF-guided arm had a larger reduction in LVEF at follow-up than in the GLS-guided arm (9.1±10.9% versus 2.9±7.4%, p=0.03). CONCLUSIONS Although the change in LVEF was not different between the two arms, GLS-guided CPT significantly reduced a meaningful fall of LVEF to the abnormal range. The results support the use of GLS in surveillance for CTRCD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2020.11.020

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 387

Metadata

Authors
Thavendiranathan, P., Negishi, T., Somerset, E., Negishi, K., Penicka, M., Lemieux, J., Aakhus, S., Miyazaki, S., Shirazi, M., Galderisi, M., Marwick, T. H., Negishi, K., Costello, B., Wright, L., La Gerche, A., Mottram, P., Thomas, L., Shirazi, M., Penicka, M., Ondrus, T., Seldrum, S., Hristova, K., Thavendiranathan, P., Amir, E., Thampinathan, B., Lemieux, J., Cote, M.-A., Deblois, J., Bansal, M., Galderisi, M., Santoro, C., Kurosawa, K., Fukuda, N., Yamada, H., Saijo, Y., Miyazaki, S., Izumo, M., Suzuki, T., Tajiri, K., Cho, G. Y., Aakhus, S., Murbræch, K., Massey, R., Kosmala, W., Sinski, M., Vinereanu, D., Mihalcea, D., Popescu, B., Calin, A., Shkolnik, E., Banchs, J., & Kutty, S.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2021-02
Volume
77
Issue
4
Pages
392-401
ISSN
0735-1097 (ISSN-L)
OpenAlex
W3103460883
Cited by
387
References
0
FWCI
31.00
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy. https://app.cochat.ai/papers/10.1016/j.jacc.2020.11.020
The paper
Thavendiranathan, P., Negishi, T., Somerset, E., Negishi, K., Penicka, M., Lemieux, J., Aakhus, S., Miyazaki, S., Shirazi, M., Galderisi, M., Marwick, T. H., Negishi, K., Costello, B., Wright, L., La Gerche, A., Mottram, P., Thomas, L., Shirazi, M., Penicka, M., . . . Kutty, S. (2021). Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2020.11.020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.